Paul B. Savage

18.6k total citations · 3 hit papers
290 papers, 15.3k citations indexed

About

Paul B. Savage is a scholar working on Molecular Biology, Microbiology and Immunology. According to data from OpenAlex, Paul B. Savage has authored 290 papers receiving a total of 15.3k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Molecular Biology, 96 papers in Microbiology and 79 papers in Immunology. Recurrent topics in Paul B. Savage's work include Antimicrobial Peptides and Activities (95 papers), Immune Cell Function and Interaction (65 papers) and T-cell and B-cell Immunology (32 papers). Paul B. Savage is often cited by papers focused on Antimicrobial Peptides and Activities (95 papers), Immune Cell Function and Interaction (65 papers) and T-cell and B-cell Immunology (32 papers). Paul B. Savage collaborates with scholars based in United States, Poland and Türkiye. Paul B. Savage's co-authors include Albert Bendelac, Luc Teyton, Richard M. Epand, Carlos Cantu, Dapeng Zhou, Jochen Mattner, Reed M. Izatt, Jerald S. Bradshaw, Robert Bucki and Ning Yin and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Paul B. Savage

285 papers receiving 15.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Biology of NKT Cells

2006 1.8k citations Albert Bendelac, Paul B. Savage et al. profile →
Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections

2005 895 citations Jochen Mattner, Carlos Cantu et al. profile →
Lysosomal Glycosphingolipid Recognition by NKT Cells

2004 780 citations Dapeng Zhou, Jochen Mattner et al. Science profile →

Peers

Countries citing papers authored by Paul B. Savage

Since Specialization

Citations

This map shows the geographic impact of Paul B. Savage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul B. Savage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul B. Savage more than expected).

Fields of papers citing papers by Paul B. Savage

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul B. Savage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul B. Savage. The network helps show where Paul B. Savage may publish in the future.

Co-authorship network of co-authors of Paul B. Savage

This figure shows the co-authorship network connecting the top 25 collaborators of Paul B. Savage. A scholar is included among the top collaborators of Paul B. Savage based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul B. Savage. Paul B. Savage is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Bactericidal activity of ceragenin CSA-13, CSA-44 and CSA-131 against bacteria causing bloodstream infections 2025 ·Frontiers in Microbiology ·(unknown), (unknown), Łukasz Suprewicz, (unknown), (unknown), Grzegorz Król, (unknown), (unknown), Bonita Durnaś, Tamara Daniluk, Ewelina Piktel, Paul B. Savage, Robert Bucki	0
2	Investigating the Effectiveness of Ceragenins against Acinetobacter baumannii to Develop New Antimicrobial and Anti-Adhesive Strategies 2024 ·International Journal of Molecular Sciences ·(unknown), Urszula Wnorowska, Tamara Daniluk, Piotr Deptuła, (unknown), (unknown), Bonita Durnaś, Karol Skłodowski, (unknown), Paul B. Savage, Ewelina Piktel, Robert Bucki	3
3	Incorporation of Ceragenins into Medical Adhesives and Adhesive Scar Tape to Prevent Microbial Colonization Common in Healthcare-Associated Infections 2024 ·Antibiotics ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Lauren E. Kelly, (unknown), (unknown), (unknown), (unknown), (unknown), Mark R. Tolley, (unknown), (unknown), Shenglou Deng, James E. Patterson, Paul B. Savage	1
4	Repositioning the Early Pathology of Type 1 Diabetes to the Extraislet Vasculature 2024 ·The Journal of Immunology ·Anne Costanzo, (unknown), (unknown), (unknown), (unknown), (unknown), Lisa Kain, Brian T. Abe, Sandrine Luce, Christian Boîtard, Tine Wyseure, Laurent O. Mosnier, Andrew I. Su, Catherine L. Grimes, M. G. Finn, Paul B. Savage, Michael Gottschalk, Jeremy Pettus, Luc Teyton	0
5	Antibacterial Plasma Polymer Coatings on 3D Materials for Orthopedic Applications 2023 ·Advanced Materials Interfaces ·Aiken Dao, (unknown), (unknown), Omid Sharifahmadian, Richard P. Tan, Steven G. Wise, (unknown), Marcela Bilek, Paul B. Savage, Aaron Schindeler, Behnam Akhavan	9
6	Efficacy of Ceragenins Alone and in Combinations with Antibiotics Against Multidrug-Resistant Gram Negative Pathogens from Bloodstream Infections 2023 ·Current Microbiology ·(unknown), Lütfiye Öksüz, (unknown), Sibel Döşler, Paul B. Savage, Çagla Bozkurt-Güzel	4
7	Unravelling the structural complexity of glycolipids with cryogenic infrared spectroscopy 2021 ·Nature Communications ·Carla Kirschbaum, Kim Greis, Eike Mucha, Lisa Kain, Shenglou Deng, (unknown), Sandy Gewinner, Wieland Schöllkopf, Gert von Helden, Gerard Meijer, Paul B. Savage, Mateusz Marianski, Luc Teyton, Kevin Pagel	52
8	Synthesis of the pentasaccharide repeating unit fromRuminococcus gnavusand measurement of its inflammatory properties 2021 ·RSC Advances ·(unknown), (unknown), Christoph Drees, (unknown), (unknown), (unknown), Albert Bendelac, Shenglou Deng, Paul B. Savage	10
9	Bactericidal Properties of Rod-, Peanut-, and Star-Shaped Gold Nanoparticles Coated with Ceragenin CSA-131 against Multidrug-Resistant Bacterial Strains 2021 ·Pharmaceutics ·Sylwia Chmielewska, Karol Skłodowski, Joanna Depciuch, Piotr Deptuła, Ewelina Piktel, Krzysztof Fiedoruk, (unknown), (unknown), (unknown), Tomasz Wollny, Przemysław Wolak, Magdalena Parlińska‐Wojtan, Paul B. Savage, Robert Bucki	28
10	Ceragenin-Coated Non-Spherical Gold Nanoparticles as Novel Candidacidal Agents 2021 ·Pharmaceutics ·Karol Skłodowski, Sylwia Chmielewska, Joanna Depciuch, Piotr Deptuła, Ewelina Piktel, Tamara Daniluk, Magdalena Zakrzewska, (unknown), Mateusz Cieśluk, Bonita Durnaś, Magdalena Parlińska‐Wojtan, Paul B. Savage, Robert Bucki	12
11	Synergistic Activity of Ceragenins Against Carbapenem-Resistant Acinetobacter baumannii Strains in Both Checkerboard and Dynamic Time-Kill Assays 2020 ·Current Microbiology ·Çagla Bozkurt-Güzel, (unknown), (unknown), Paul B. Savage	13
12	Antibiofilm activities of ceragenins and antimicrobial peptides against fungal-bacterial mono and multispecies biofilms 2020 ·The Journal of Antibiotics ·Mayram Hacıoğlu, (unknown), Çagla Bozkurt-Güzel, Paul B. Savage	26
13	Effects of ceragenins and conventional antimicrobials on Candida albicans and Staphylococcus aureus mono and multispecies biofilms 2019 ·Diagnostic Microbiology and Infectious Disease ·Mayram Hacıoğlu, Ebru Hacıosmanoğlu, (unknown), Çagla Bozkurt-Güzel, Paul B. Savage	26
14	Antibacterial and Antibiofilm Activities of Ceragenins against <i>Pseudomonas aeruginosa</i> Clinical Isolates 2019 ·Turkish Journal of Pharmaceutical Sciences ·Çagla Bozkurt-Güzel, Mayram Hacıoğlu, (unknown), Paul B. Savage	6
15	Discrete TCR Binding Kinetics Control Invariant NKT Cell Selection and Central Priming 2016 ·The Journal of Immunology ·(unknown), Nichole Escalante, Shenglou Deng, (unknown), June Ereño‐Orbea, Paul B. Savage, Jean‐Philippe Julien, Thierry Mallevaey	27
16	YAP-Induced Resistance of Cancer Cells to Antitubulin Drugs Is Modulated by a Hippo-Independent Pathway 2014 ·Cancer Research ·Yulei Zhao, Prem Khanal, Paul B. Savage, Yi‐Min She, Terry D. Cyr, Xiaolong Yang	80
17	Ceragenins – a new weapon to fight multidrug resistant bacterial infections 2014 ·Medical Studies ·(unknown), Katarzyna Niemirowicz, Michał Marzec, Paul B. Savage, Robert Bucki	23
18	Depolarization, Bacterial Membrane Composition, and the Antimicrobial Action of Ceragenins 2010 ·Antimicrobial Agents and Chemotherapy ·(unknown), (unknown), (unknown), Jonathan O. Wright, Paul B. Savage, Richard M. Epand	160
19	Lysosomal Glycosphingolipid Recognition by NKT Cells breakdown → 2004 ·Science ·Dapeng Zhou, Jochen Mattner, Carlos Cantu, Nicolas Schrantz, Ning Yin, Ying Gao, Yuval Sagiv, Kelly Hudspeth, (unknown), Tadashi Yamashita, Susann Teneberg, Dacheng Wang, Richard L. Proia, Steven B. Levery, Paul B. Savage, Luc Teyton, Albert Bendelac	780
20	Editing of CD1d-Bound Lipid Antigens by Endosomal Lipid Transfer Proteins 2003 ·Science ·Dapeng Zhou, Carlos Cantu, Yuval Sagiv, Nicolas Schrantz, Ashok B. Kulkarni, Xiaoyang Qi, Don J. Mahuran, Carlos R. Morales, Gregory A. Grabowski, Kamel Benlagha, Paul B. Savage, Albert Bendelac, Luc Teyton	263

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact